|Loss in Body Weight||98% of patients lost an average of 14 lbs (SD: 16.0) or 6.1% (SD: 6.2) of body weight (p < .00015).|
|Change in BMI||BMI decreased an average of 6.2% (SD: 6.5) in all patients with a mean reduction from 36.4 (SD: 6.3) to 34.1 (SD: 5.7) (p < .0001).|
|Reduction in Fat||Fat mass decreased an average of 16.6% (SD: 17.1) (p < .0001).|
|Improvement in Body Composition||The body’s lean mass composition increased from 61.6% (SD: 8.0) to 65.8% (SD: 9.4) or an average increase of 4.2% (p < .0001).|
There was no significant difference in absolute lean mass pre- and post-intervention. However, overall body composition improved because of the increase in lean mass percentage in the body. The changes were the same in both men and women with no effect of age. Patients were enrolled in the program an average of 26 weeks.
Length of time in the program was significantly correlated with a decrease in fat mass and improved body composition as determined by the percent increase in lean mass (p < .0001) (Figures 1 and 2).
Bariatrician led team based approach per the USPSTF recommendations can implement effective intervention for the high health care utilizers identified by the ‘Corporate Wellness’ program. These chronic patients often have difficulty coordinating care between providers. The relative risk of Diabetes increases by 25% for each additional unit of BMI over 22 kg/m2, and the American Heart Association has listed obesity as a major modifiable risk factor for heart disease. A Bariatrician led team delivered significant reduction in BMI (ROH) in this patient population by managing, treating and reversing Obesity and associated co-morbidities. These patients are among the 10% that lead to 70% of the healthcare expenses. The employers can engage with an OMA/ABOM trained Bariatrician to leverage their current investment in ‘Corporate Wellness’, and address the needs of their high health care utilizer employees as identified by their ‘Corporate Wellness Vendor’.
Potential Cost Avoidance Calculation based on BMI reduction, and reduction of risk factors for Type 2 Diabetes and Heart Disease.